DOX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amdocs Ltd (DOX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown modest financial growth and maintains positive partnerships, the technical indicators suggest a bearish trend, and the options data reflects a bearish sentiment. Additionally, hedge funds are selling the stock, and analysts have recently lowered price targets. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in this stock right now.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 43.64, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 68.521, with support levels at 66.382 and 65.06, and resistance levels at 70.66 and 71.982. Overall, the technical indicators suggest a bearish trend.
Amdocs has extended its partnership with Vodafone Germany to enhance customer experience and operational efficiency. Additionally, the T-Mobile contract renewal alleviates a key investor concern.
Hedge funds are significantly increasing their selling activity, with a 1713.29% increase in selling over the last quarter. Analysts have lowered price targets, citing macroeconomic pressures on Amdocs' end markets. The stock is also showing a bearish trend in technical indicators.
In Q1 2026, Amdocs reported a 4.13% YoY increase in revenue to $1.155 billion, a 4.17% YoY increase in net income to $154.5 million, and a 9.02% YoY increase in EPS to $1.45. However, gross margin dropped by 3.58% YoY to 35.79%, which could indicate rising costs or pricing pressures.
Analysts remain cautiously optimistic with Buy and Overweight ratings, but recent price target reductions (Barclays to $92 from $111, Stifel to $88 from $97) reflect concerns about macroeconomic headwinds impacting Amdocs' end markets. Analysts do acknowledge the company's resilient results and strategic wins.
